Related Experiment Videos
New antiherpetic nucleoside from a Basidiomycete
D Saboulard1, A Gaspar, B Roussel
1Laboratoire de mycologie appliquée aux biotechnologies industrielles, Institut des sciences pharmaceutiques et biologiques de Lyon, université Claude-Bernard-Lyon-I, France.
Summary
Researchers discovered antiviral activity in the fungus Macrocystidia cucumis. This activity targets herpes simplex virus type 1 (HSV-1) and is linked to a novel compound called McA.
Area of Science:
- Mycology
- Virology
- Natural Product Chemistry
Background:
- Basidiomycete fungi are a source of bioactive compounds.
- Herpes simplex virus type 1 (HSV-1) causes significant human infections.
- Antiviral agents are crucial for managing viral diseases.
Purpose of the Study:
- To investigate antiviral activity in the culture broth of Macrocystidia cucumis.
- To isolate and characterize the compound responsible for antiviral effects against HSV-1.
Main Methods:
- Cultivation of Macrocystidia cucumis.
- ELISA assay for antiviral activity detection.
- Semi-preparative High-Performance Liquid Chromatography (HPLC) for purification.
- Cytotoxicity assays.
Main Results:
- Culture broth exhibited antiviral activity against HSV-1 in baby hamster kidney cells (BHK-21).
- A novel purine nucleoside, designated McA, was isolated and identified as the active principle.
- McA showed no cytotoxicity at effective antiviral concentrations.
Conclusions:
- Macrocystidia cucumis produces a novel nucleoside analogue with potent antiviral activity against HSV-1.
- McA represents a promising candidate for further development as an antiviral therapeutic.